Simona Skerjanec
Directeur/Membre du Conseil chez AVIDITY BIOSCIENCES, INC.
Fortune : - $ au 31/05/2024
Provenance du réseau au premier degré de Simona Skerjanec
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 15 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Simona Skerjanec via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ALEXION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal | |
| EDWARDS LIFESCIENCES CORPORATION | Medical Specialties | Corporate Officer/Principal | |
| CATALYST PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
ZP Opco, Inc.
 ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Director/Board Member | |
Wildcat Discovery Technologies, Inc.
 Wildcat Discovery Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Wildcat Discovery Technologies, Inc. provides commercial research and development services. The firm engages in development projects for materials for other applications, including gas storage, carbon capture, thermoelectric, and structural materials. Its products include electrolyte additives such as EM1, CM1, CM2, and EM2. The company was founded by Peter G. Schultz and Robert K. Downs in 2006 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Founder | |
| ORGANOVO HOLDINGS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Arcturus Therapeutics, Inc.
 Arcturus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arcturus Therapeutics, Inc. engages in the development of technology and therapeutics for rare diseases. It specializes in the application of application of ribonucleic acid technologies for the treatment of disease. The company was founded by Joseph E. Payne and Padmanabh Chivukula in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Araxes Pharma LLC
 Araxes Pharma LLC Pharmaceuticals: MajorHealth Technology Araxes Pharma LLC develops drugs for the treatment of cancer and other diseases. The private company is based in La Jolla, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| KURA ONCOLOGY, INC. | Biotechnology | Chief Executive Officer | |
| University of Pennsylvania | College/University | Doctorate Degree | |
| Boston University | College/University | Undergraduate Degree | |
| Imperial College London | College/University | Doctorate Degree | |
| MERRIMACK PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Public Communications Contact | |
| San Diego State University | College/University | Graduate Degree | |
| Long Island University | College/University | Graduate Degree | |
| New York University | College/University | Graduate Degree | |
| University of Wisconsin | College/University | Undergraduate Degree | |
| University of California, Berkeley | College/University | Doctorate Degree | |
Presidio Partners
 Presidio Partners Investment ManagersFinance Presidio Partners is a venture capital firm founded in the year 1989 by Thomas R. Baruch. The firm is headquartered in San Francisco, California. | Investment Managers | Private Equity Investor | |
| AMBRX INC | Pharmaceuticals: Major | General Counsel Founder | |
| The State University of New York | College/University | Undergraduate Degree | |
National Pharmaceutical Council
 National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member | |
| AKCEA THERAPEUTICS, INC. | Pharmaceuticals: Major | President Director of Finance/CFO Investor Relations Contact | |
| STOKE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Pharmaceuticals: Major | President | |
Abintus Bio, Inc.
 Abintus Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Abintus Bio, Inc. operates as a preclinical stage gene therapy company. It provides immune cell reprogramming services. The company was founded by John Snyder, Nicholas A. Boyle, Douglas J. Jolly, Carlos Ibañez, Derek Ostertag, and Cory Bentley and is headquartered in Encinitas, CA. | Miscellaneous Commercial Services | Chairman | |
Wellspring Biosciences LLC
 Wellspring Biosciences LLC Pharmaceuticals: MajorHealth Technology Wellspring Biosciences LLC discovers and develops molecule drugs targeting signal transduction networks for the treatment of cancer and other diseases. The private company is based in La Jolla, CA. The company was founded by Pingda Ren. | Pharmaceuticals: Major | Chairman | |
| ZOSANO PHARMA CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
| PUMA BIOTECHNOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Seton Hall University School of Law | College/University | Graduate Degree | |
Cognoa, Inc.
 Cognoa, Inc. Medical/Nursing ServicesHealth Services Cognoa, Inc. offers a mobile application and proprietary algorithm to enable early detection of autism. The firm is a consumer healthcare company that?s changing how parents assess and support their child?s development. The company was founded by Dennis Wall and Brent Vaughan and is headquartered in Palo Alto, CA. | Medical/Nursing Services | Chief Operating Officer | |
| AUDENTES THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Biogen Idec Ltd.
 Biogen Idec Ltd. BiotechnologyHealth Technology Biogen Idec Ltd. develops therapies for neurodegenerative, haematologic, and autoimmune disorders. The firm develops treatment for Alzheimer’s Disease, spinal muscular atrophy, lupus, and amyotrophic lateral sclerosis (ALS), amongst others. The company was founded on 2003 and is headquartered in Maidenhead, the United Kingdom. | Biotechnology | Corporate Officer/Principal | |
| Imperial College Business School | College/University | Masters Business Admin | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Lazard Healthcare Acquisition Corp. I
 Lazard Healthcare Acquisition Corp. I Financial ConglomeratesFinance Lazard Healthcare Acquisition Corp. I is a blank check company, which engages in mergers, share exchanges, asset acquisitions, share purchases, and reorganizations. The company was founded on February 25, 2021 and is headquartered in New York, NY. | Financial Conglomerates | Director/Board Member | |
| LAZARD GROWTH ACQUISITION CORP. I | Semiconductors | Director/Board Member |
Statistiques
Internationale
| Etats-Unis | 42 |
| Royaume-Uni | 4 |
| Irlande | 2 |
| Hong Kong | 2 |
| Îles Cayman | 2 |
Sectorielle
| Health Technology | 27 |
| Consumer Services | 12 |
| Commercial Services | 6 |
| Finance | 3 |
| Miscellaneous | 2 |
Opérationnelle
| Corporate Officer/Principal | 53 |
| Director/Board Member | 39 |
| Independent Dir/Board Member | 25 |
| Undergraduate Degree | 13 |
| President | 11 |
Relations les plus connectées
| Insiders | |
|---|---|
| Troy Wilson | 17 |
| Carsten Boess | 15 |
| Edward Kaye | 13 |
| Sarah Boyce | 12 |
| Michael MacLean | 11 |
| Arthur Levin | 10 |
| Noreen Henig | 10 |
| John W. Wallen | 9 |
| W. Flanagan | 8 |
| Eric B. Mosbrooker | 8 |
| Steven G. Hughes | 8 |
| Jean Kim | 7 |
| Tamar Thompson | 6 |
| Teresa McCarthy | 5 |
| Kathleen Gallagher | 4 |
- Bourse
- Insiders
- Simona Skerjanec
- Connexions Sociétés
